工程化CGRP滴眼液经TRPM8-SSN通路恢复屈光术后干眼泪液分泌
该研究在小鼠角膜神经切断及PRK模型中,发现角膜CGRP含量下降伴随干眼症状,预防性或治疗性CGRP可经TRPM8-SSN神经通路 rescue 泪液分泌。与天然CGRP相比,工程化CGRP(eCGRP)局部应用在增加泪液分泌、恢复上皮稳态和减轻角膜炎症方面更优,且无疼痛相关副作用。
要点
- 角膜神经切断致角膜CGRP下降,引发泪液分泌减少和上皮屏障功能障碍。
- CGRP通过增强TRPM8-SSN泪液分泌神经通路改善术后干眼。
- eCGRP局部应用疗效优于天然CGRP,且无疼痛相关副作用。
核心结论
- 屈光术后干眼中角膜CGRP表达下调,与TRPM8-SSN活动降低相关。
- eCGRP可能为屈光术后干眼的预防和治疗提供有效方法。
研究设计与样本
- 在成年C57BL/6J小鼠中通过手术切断角膜神经建立模型,并用PRK模型验证。
- 术后评估角膜敏感性、角膜神经密度、泪液分泌、角膜荧光素染色、免疫荧光和角膜RNA测序。
- 检测三叉神经节TRPM8、c-FOS及脑上唾液核(SSN)在体电生理记录,并评估CGRP与eCGRP疗效。
主要发现
- 角膜神经切断导致角膜CGRP含量显著降低,伴泪液分泌减少、上皮屏障功能障碍和基底神经下丛变性。
- 预防性CGRP有效 rescue 上述病理改变,治疗性CGRP通过增强完整泪液分泌神经通路显著减轻病变。
- 与天然CGRP相比,eCGRP局部应用在增加泪液分泌、恢复上皮稳态和减少角膜炎症方面疗效更优,且无疼痛相关副作用。
- 在激光PRK模型中,eCGRP同样减轻干眼,证实其在更临床相关手术中的疗效。
临床怎么用
- eCGRP滴眼液可能用于屈光术后干眼的预防和治疗,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate the role of sensory neuropeptide calcitonin gene-related peptide (CGRP) in postrefractive surgery dry eye caused by corneal nerve severing in mice. METHODS: A mouse model was established in adult C57BL/6J mice by surgical corneal severing. Additional validation was performed using a photorefractive keratectomy (PRK) model. Postoperative evaluations included corneal sensitivity, corneal nerve density, tear secretion, corneal fluorescein staining, immunofluorescence staining, and corneal RNA sequencing. Transient receptor potential melastatin 8 (TRPM8) of the trigeminal ganglia (TG), c-FOS, and in vivo electrophysiologic recording of the brain superior salivatory nucleus (SSN) were determined. The therapeutic efficacy of CGRP and an engineered CGRP (eCGRP) was assessed in treating postrefractive surgery dry eye. RESULTS: Corneal nerve severing led to a significant reduction of corneal CGRP contents, accompanied by the development of dry eye symptoms, including tear secretion reduction, epithelial barrier dysfunction, and subbasal nerve degeneration. These pathologic alterations were effectively rescued by prophylactic CGRP and significantly attenuated by therapeutic CGRP via enhancing the intact neural circuit of tear secretion. Compared with native CGRP, topical application of eCGRP exhibited superior efficacy of increasing tear secretion, restoring epithelial homeostasis, and reducing corneal inflammation, without pain-related side effects. In the laser-based PRK model, eCGRP similarly alleviated dry eye, confirming its therapeutic efficacy in a more clinically relevant surgery. CONCLUSIONS: Our data demonstrate that CGRP expression in the cornea is downregulated in postrefractive surgery dry eye through decreasing TRPM8-SSN activity. eCGRP may provide an effective therapeutic approach for its prevention and treatment.
引用
- Zhang M, Bai X, Li X, et al. Engineered CGRP Eye Drops Restore Tear Secretion via TRPM8-SSN Circuitry in a Postrefractive Surgery Mouse Model. Invest Ophthalmol Vis Sci. 2026. PMID: 41563016. doi:10.1167/iovs.67.1.45
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。